Biotech News
-
Rritual Superfoods Chief Innovation Officer Establishes Innovation Division
May 5, 2021 (Source) — Recently Appointed, Stacey Gillespie, Advances R&D Practices and Fuels Rritual’s Functional Superfoods Product Pipeline for National Rollout Rritual Superfoods Inc.…
-
Perimeter Medical Imaging AI Reports 2020 Financial Results and Provides Corporate Update
April 30, 2021 (Source) — Perimeter Medical Imaging AI, Inc. (TSX-V:PINK)(OTC:PYNKF) (FSE:4PC) (“Perimeter” or the “Company”), a medical technology…
-
Hemostemix Provides a Clinical Trial Update and Announces the Release and Filing of 2020 Year-end Audited Financial Statements and Management Discussion and Analysis
April 30, 2021 (Source) — Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (FSE: 2VF0) (“Hemostemix” or the “Company”) is pleased…
-
Valeo Pharma Announces Voting Results of its 2021 Annual General and Special Meeting of Shareholders
April 29, 2021 (Source) — Valeo Pharma Inc. (CSE: VPH) (OTCQB: VPHIF) (FSE: VP2) (“Valeo” or the “Company”), a…
-
Rritual Superfoods Third Full Scale Manufacturing Run is Scaled to Meet Growing Retail Demand
April 29, 2021 (Source) — Production Designed to Serve Recently Announced CROSSMARK Driven Rollout Rritual Superfoods Inc. (“Rritual” or the “Company”) (CSE:…
-
Valeo Pharma’s Redesca® and Redesca HP® to Be Covered Under the Ontario Public Drug Benefit Program
April 28, 2021 (Source) — Ontario represents 37% of the Canadian low molecular weight heparin market Additional provincial coverage…
-
XPhyto Pursues Market Access in Israel for its COVID-19 PCR Rapid Test
April 28, 2021 (Source) — XPhyto delivered 2,000 of its 25-minute PCR tests to Israeli distributor for clinical…
-
Red Light Holland and Halo Collective Create Red Light Oregon, Inc. – Forwarding Intentions to Enter Oregon Medicinal Psychedelic Market
April 27, 2021 (Source) — Further to the joint press release dated Nov 19, 2020, Halo Collective Inc. (“Halo”)…
-
Valeo Pharma Upsizes And Closes $6.6 Million Non-Brokered Private Placement
April 27, 2021 (Source) — Valeo insiders participation of $2.6 million Valeo Pharma Inc. (CSE: VPH) (OTCQB: VPHIF) (FSE:…
-
Hemostemix Reprices and Amends the Terms of Its Unit Offering and Debenture Offering
April 26, 2021 (Source) — Hemostemix Inc. (TSXV: HEM) (OTC Pink: HMTXF) (FSE: 2VFO.F) (“Hemostemix” or the “Company”)…
